These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052 [TBL] [Abstract][Full Text] [Related]
7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
9. Correlation among pathology, genotype, and patient outcomes in glioblastoma. Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578 [TBL] [Abstract][Full Text] [Related]
10. Association of loss of heterozygosity with shorter survival in primary glioblastoma patients. Jesionek-Kupnicka D; Szybka M; Potemski P; Kulczycka-Wojdala D; Jaskólski D; Bieńkowski M; Skowroński W; Papierz W; Kordek R; Zawlik I Pol J Pathol; 2013 Dec; 64(4):268-75. PubMed ID: 24375041 [TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity. Thiessen B; Maguire JA; McNeil K; Huntsman D; Martin MA; Horsman D J Neurooncol; 2003 Sep; 64(3):271-8. PubMed ID: 14558604 [TBL] [Abstract][Full Text] [Related]
12. Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment? Ramirez C; Bowman C; Maurage CA; Dubois F; Blond S; Porchet N; Escande F Neuro Oncol; 2010 May; 12(5):490-9. PubMed ID: 20156805 [TBL] [Abstract][Full Text] [Related]
13. 1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis. Durand KS; Guillaudeau A; Weinbreck N; DeArmas R; Robert S; Chaunavel A; Pommepuy I; Bourthoumieu S; Caire F; Sturtz FG; Labrousse FJ Mod Pathol; 2010 Apr; 23(4):619-28. PubMed ID: 20081802 [TBL] [Abstract][Full Text] [Related]
14. Genetic analyses for predictors of radiation response in glioblastoma. Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739 [TBL] [Abstract][Full Text] [Related]
15. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932 [TBL] [Abstract][Full Text] [Related]
16. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672 [TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770 [TBL] [Abstract][Full Text] [Related]
20. Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China. Li S; Yan C; Huang L; Qiu X; Wang Z; Jiang T Neuro Oncol; 2012 Jan; 14(1):109-16. PubMed ID: 22039037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]